Fresh analysis suggests that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Research printed in a prominent health publication points out that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"People using these medications need to be cognizant of the potential of rapid rebound weight gain when the medication ends," warns lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment weight within about a year and a half.
Weighing Treatments
The research, which examined dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
The team point out that people who shed pounds through diet and exercise typically have a more gradual creep back—perhaps 0.1 kg a month—post-intervention.
Explaining the Rapid Rebound
Nutrition scientists propose the mechanism of the jabs is key to understanding the amplified rebound.
These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making excessive eating far more likely."
A Lifelong Condition?
Health authorities recommend the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the high risk of relapse, the treatment might need to be life-long.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the long-term character of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have stopped the medication report a sudden resurgence of appetite.
"I experienced a switch that goes on and you're instantly extremely hungry," described an individual.
The struggle is compounded if patients have not adopted sustainable dietary or behavioural modifications during therapy.
Growing Use
Survey data suggest that millions of adults in the UK have used these injections in the past year, with interest being substantial.
- Use is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while these medications are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits hinges on integrated behavioural support.
